Antibody Validation
Antibody Validation - Related Videos
08:09
Validation of Nanobody and Antibody Based In Vivo Tumor Xenograft NIRF-imaging Experiments in Mice Using Ex Vivo Flow Cytometry and Microscopy
0 Views •
Cited by 24 •
2015
This protocol outlines the steps required to perform ex vivo validation of in vivo near-infrared fluorescence xenograft imaging experiments in mice using fluorophore labelled nanobodies and conventional antibodies.
01:29
Reliability and Validity
0 Views •
2020
Reliability and validity are two important considerations that must be made with any type of data collection. Reliability refers to the ability to consistently produce a given result. In the context of psychological research, this would mean that any instruments or tools used to collect data do so in consistent, reproducible ways. Unfortunately, being consistent in measurement does not necessarily mean that you have measured something correctly. To illustrate this concept, consider a kitchen...
13:21
Antibody Generation: Producing Monoclonal Antibodies Using Hybridomas
0 Views •
2023
Source: Frances V. Sjaastad1,2, Whitney Swanson2,3, and Thomas S. Griffith1,2,3,4 1 Microbiology, Immunology, and Cancer Biology Graduate Program, University of Minnesota, Minneapolis, MN 55455 2 Center for Immunology, University of Minnesota, Minneapolis, MN 55455 3 Department of Urology, University of Minnesota, Minneapolis, MN 55455 4 Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455 Polyclonal antibodies are defined as a collection of antibodies directed against...
01:10
Antibody Structure
0 Views •
2019
Overview Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding. The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains Antibodies consist of four polypeptide chains: two identical heavy...
12:55
Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries
0 Views •
Cited by 33 •
2015
A method is described with visual accompaniment for conducting scalable, high throughput selections from phage-displayed combinatorial synthetic antibody libraries against hundreds of antigens simultaneously. Using this parallel approach, we have isolated antibody fragments that exhibit high affinity and specificity for diverse antigens that are functional in standard immunoassays.
FAQs
Controls help separate target-related signal from background. A positive control shows whether the antibody can produce the expected signal under the test conditions, while a negative control helps reveal nonspecific binding or signal that occurs without the intended target. Reviewing both controls makes it easier to judge whether a result reflects target detection rather than a technical artifact.
Orthogonal methods examine antibody performance through an independent experimental approach. Genetic depletion, immunoblotting, immunoprecipitation, or comparison with an independent antibody can provide separate evidence about the identity of the detected signal. Agreement across methods increases confidence that the antibody recognizes the intended target, while disagreement can expose cross-reactivity or other limitations requiring further investigation.
Specificity concerns whether the signal represents the intended target rather than an unrelated molecule. Sensitivity concerns the antibody’s ability to produce a measurable signal, whereas reproducibility concerns whether results remain consistent across testing conditions or antibody lots. Considering all three properties prevents a strong signal alone from being mistaken for reliable target measurement.
A basic workflow compares antibody signal with appropriate positive and negative controls, then uses an additional supported method when stronger evidence is needed. Researchers may examine results through tissue staining, cell analysis, immunoblotting, immunoprecipitation, genetic depletion, or an independent antibody. This comparison helps determine whether observed signal is suitable for interpreting biological or medical samples.
Different antibody lots can produce inconsistent measurements, even when investigators are examining the same target. Assessing lot-to-lot variation supports reproducibility and helps identify whether changes in tissue staining, cell analysis, or biomarker measurements reflect biology or reagent performance. This check is especially important when results must remain comparable across experiments or support later translational work.
Reliable antibody measurements strengthen disease investigation, biomarker studies, and therapeutic development by improving confidence in the detected signal. In medicine, validated reagents can help connect laboratory observations from tissues or cells with findings that may be evaluated for clinical relevance. Careful validation therefore supports more dependable interpretation when research results move toward clinical applications.